Z Li, M Maglione, W Tu, W Mojica, D … - Annals of internal medicine, 2005 - Am Coll Physicians Background: In response to the increase in obesity, pharmacologic treatments for
weight loss have become more numerous and more commonly used. ... Purpose: To
assess the efficacy and safety of weight loss medications approved by the ... Cited by 321 - Related articles - BL Direct - All 8 versions
D Sources, D Extraction, D Synthesis - Ann Intern Med, 2005 - Am Coll Physicians Background: In response to the increase in obesity, pharmaco- logic treatments
for weight loss have become more numerous and more commonly used. Purpose: To
assess the efficacy and safety of weight loss med- ications approved by the ... Related articles - All 4 versions
DE Arterburn, PK Crane, DL Veenstra - Archives of Internal Medicine, 2004 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 177 - Related articles - BL Direct - All 5 versions
- ►dkmic.de [PDF] TA Wadden, RI Berkowitz, LG Womble, DB … - The New England journal of medicine, 2005 - nejm.highwire.org From the University of Pennsylvania School of Medicine, Philadelphia (TAW, RIB,
LGW, DBS, RKC, LAH, SYO, AJS); the Children's Hospital of Philadelphia,
Philadelphia (RIB); Brown Medical School, Providence, RI (SP); and Glaxo- ... Cited by 294 - Related articles - BL Direct - All 12 versions
- ►annals.org V Snow, P Barry, N Fitterman, A Qaseem, K … - Annals of internal medicine, 2005 - Am Coll Physicians This guideline is based on the evidence report and accompanying background
papers developed by the Southern California Evidence-Based Practice Center. The
American College of Physicians nominated this topic to the Agency for ... Cited by 118 - Related articles - All 7 versions
JS Torgerson, J Hauptman, MN Boldrin, L … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—Of orlistat-treated patients, 52% completed treatment compared with
34% of placebo recipients (P < 0.0001). After 4 years' treatment, the cumulative
incidence of diabetes was 9.0% with placebo and 6.2% with orlistat, ... Cited by 722 - Related articles - BL Direct - All 10 versions
- ►annals.org MA Maggard, LR Shugarman, M Suttorp, M … - Annals of internal medicine, 2005 - Am Coll Physicians From the Southern California Evidence-Based Practice Center (which includes RAND
Health Division, Santa Monica, California, and the Greater Los Angeles VA
Healthcare System, Los Angeles) and the University of California, Los ... Cited by 452 - Related articles - BL Direct - All 10 versions
TA Wadden, RI Berkowitz, LG Womble, DB … - Obesity, 2000 - nature.com Research Methods and Procedures: Patients were 34 women with a mean age of 44.1
10.4 years, weight of 89.4 13.8 kg, and body mass index (BMI) of 33.9 4.9 kg/m 2
who had lost an average of 11.6 9.2% of initial weight during the prior 1 ... Cited by 112 - Related articles - BL Direct - All 2 versions
- ►lindaxa.cz [PDF] WPT James, A Astrup, N Finer, J Hilsted, P … - The Lancet, 2000 - Elsevier Eight European centres recruited 605 obese patients (body-mass index 30-45 kg/m
2 ) for a 6-month period of weight loss with sibutramine (10 mg/day) and an
individualised 600 kcal/day deficit programme based on measured resting ... Cited by 651 - Related articles - BL Direct - All 10 versions
CK Haddock, WS Poston, PL Dill, JP Foreyt, M … - International journal of obesity and related metabolic …, 2002 - ncbi.nlm.nih.gov AIM: This article provides the first comprehensive meta-analysis of randomized
clinical trials of medications for obesity. METHOD: Based on stringent
inclusionary criteria, a total of 108 studies were included in the final ... Cited by 128 - Related articles - BL Direct - All 2 versions
